2. Signaling Pathways
  3. Immunology/Inflammation
  4. CD2
  5. CD2 Inhibitor

CD2 Inhibitor

CD2 Inhibitors (2):

Cat. No. Product Name Effect Purity
  • HY-P99904
    Siplizumab
    		Inhibitor 99.83%
    Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody against CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells.
  • HY-P99757
    Nivatrotamab
    		Inhibitor 99.40%
    Nivatrotamab (Hu3F8-BsAb) is a humanized anti-GD2/CD3 bispecific antibody. Nivatrotamab is a CD3- and GD2-specific bsAb-based T-cell engager. Nivatrotamab can be used in research of neuroblastoma.